These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20880171)

  • 1. Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study.
    Kato M; Kamada G; Yamamoto K; Nishida U; Imai A; Yoshida T; Ono S; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1631-5. PubMed ID: 20880171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa.
    Ichikawa T; Ota H; Sugiyama A; Maruta F; Ikezawa T; Hotta K; Ishihara K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1800-5. PubMed ID: 17914953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroprotective mechanism of lafutidine, a novel anti-ulcer drug with histamine H2-receptor antagonistic activity.
    Onodera S; Shibata M; Tanaka M; Inaba N; Arai Y; Aoyama M; Lee B; Yamaura T
    Arzneimittelforschung; 1999 Jun; 49(6):519-26. PubMed ID: 10417869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment by 5-fluorouracil of the healing of gastric lesions in rats: effect of lafutidine, a histamine H2 receptor antagonist, mediated by capsaicin-sensitive afferent neurons.
    Murashima Y; Kotani T; Hayashi S; Komatsu Y; Nakagiri A; Amagase K; Takeuchi K
    Dig Dis Sci; 2009 Jan; 54(1):36-45. PubMed ID: 18594983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lafutidine, a novel histamine H2-receptor antagonist, on monochloramine-induced gastric lesions in rats: role of capsaicin-sensitive sensory neurons.
    Umeda M; Fujita A; Nishiwaki H; Takeuchi K
    J Gastroenterol Hepatol; 1999 Sep; 14(9):859-65. PubMed ID: 10535466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M; Banba M; Joko A; Moriyama Y
    Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neutrophil activation by lafutidine, an H2-receptor antagonist, through enhancement of sensory neuron activation contributes to the reduction of stress-induced gastric mucosal injury in rats.
    Harada N; Okajima K
    Dig Dis Sci; 2007 Feb; 52(2):469-77. PubMed ID: 17211693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of host defense mechanism in the suppression of rat acute reflux esophagitis by the particular histamine H2 receptor antagonist lafutidine.
    Nakano M; Ajioka H; Abe M; Kiniwa M
    Pharmacology; 2012; 90(3-4):205-11. PubMed ID: 23038658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative effect of lafutidine on oral burning sensation.
    Toida M; Kato K; Makita H; Long NK; Takeda T; Hatakeyama D; Yamashita T; Shibata T
    J Oral Pathol Med; 2009 Mar; 38(3):262-8. PubMed ID: 19175712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.
    Takahashi M; Katayama Y
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1493-7. PubMed ID: 20796145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease.
    Inamori M; Iida H; Hosono K; Endo H; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Goto A; Abe Y; Hiratsuka N; Nakajima A; Fujita M
    Hepatogastroenterology; 2010; 57(104):1430-4. PubMed ID: 21443098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
    Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins.
    Fukushima K; Aoi Y; Kato S; Takeuchi K
    World J Gastroenterol; 2006 May; 12(19):3031-7. PubMed ID: 16718783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Oshitani N; Fujiwara Y; Arakawa T
    Inflammopharmacology; 2006 Dec; 14(5-6):226-30. PubMed ID: 17186182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.